Candela Introduces Next Generation Intense Pulsed Light Technology

Candela plans to introduce next generation I2PL technology for skin rejuvenation of vascular and pigmented abnormalities.

Through a partnership with Danish Dermatologic Development (DDD), Candela will expand its product portfolio to include the new Ellipse I2PL system. Candela is the exclusive distributor for the new Ellipse intense pulsed light system in the U.S.

The Ellipse features a lightweight, ergonomically shaped handpiece and allows effective treatments of large or small body areas. It successfully treats sun-damaged skin to reduce pigment and vascular disturbances.

Ellipse is the only intense pulsed light system to feature DDD's patented I2PL technology, which removes "water absorbing" wavelengths from the output spectrum device, the company said. The Ellipse I2PL system is pending FDA clearance in the U.S, after which it will be available for purchase.